Biogen
BIIB
Biogen (BIIB) news
Recent news
Biogen Inc. - deal expected to be modestly dilutive to 2026 financial results
AInvest Wire · Aug 18, 2026Biogen: HSBC raises target price to $165 from $157
AInvest Wire · Aug 10, 2026Biogen closes purchase of Raythera
AInvest Wire · Aug 6, 2026Biogen sees FY revenue $3.88B to $3.93B, saw $3.83B to $3.93B
AInvest Wire · Aug 6, 2026Alteogen - upfront and milestone payments up to $365 mln
Alteogen Inc. (KOSDAQ: 196170) has secured a significant licensing agreement with Biogen Inc., under which the company will receive upfront and milestone payments totaling up to $549 million for the development and commercialization of subcutaneous (SC) formulations of two biologic products using…
AInvest Wire · Aug 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.